Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer
RAS-MAPK 通路同时发生的改变限制了 MET 外显子 14 跳跃突变阳性肺癌患者对 MET 抑制剂治疗的反应
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-19-1667
Julia K Rotow, Philippe Gui, Wei Wu, Victoria M Raymond, Richard B Lanman, Frederic J Kaye, Nir Peled, Ferran Fece de la Cruz, Brandon Nadres, Ryan B Corcoran, Iwei Yeh, Boris C Bastian, Petr Starostik, Kimberly Newsom, Victor R Olivas, Alexander M Wolff, James S Fraser, Eric A Collisson, Caroline E